Title : Understanding changes in high density lipoproteins during the acute phase response - |
Author(s) : Van Lenten BJ , Reddy ST , Navab M , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 26 :1687 , 2006 |
PubMedID: 16857958 |
Title : Mechanisms of disease: proatherogenic HDL--an evolving field - Navab_2006_Nat.Clin.Pract.Endocrinol.Metab_2_504 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Ansell BJ , Fogelman AM |
Ref : Nat Clin Pract Endocrinol Metab , 2 :504 , 2006 |
Abstract : Navab_2006_Nat.Clin.Pract.Endocrinol.Metab_2_504 |
ESTHER : Navab_2006_Nat.Clin.Pract.Endocrinol.Metab_2_504 |
PubMedSearch : Navab_2006_Nat.Clin.Pract.Endocrinol.Metab_2_504 |
PubMedID: 16957764 |
Title : Potential clinical utility of high-density lipoprotein-mimetic peptides - Navab_2006_Curr.Opin.Lipidol_17_440 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Datta G , Garber D , Fogelman AM |
Ref : Curr Opin Lipidol , 17 :440 , 2006 |
Abstract : Navab_2006_Curr.Opin.Lipidol_17_440 |
ESTHER : Navab_2006_Curr.Opin.Lipidol_17_440 |
PubMedSearch : Navab_2006_Curr.Opin.Lipidol_17_440 |
PubMedID: 16832169 |
Title : An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice - Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Wagner AC , Hama S , Hough G , Bachini E , Garber DW , Mishra VK , Palgunachari MN , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 25 :1932 , 2005 |
Abstract : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
ESTHER : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
PubMedSearch : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
PubMedID: 15961700 |
Title : Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal - Navab_2004_Curr.Opin.Lipidol_15_645 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Datta G , Garber D , Fogelman AM |
Ref : Curr Opin Lipidol , 15 :645 , 2004 |
Abstract : Navab_2004_Curr.Opin.Lipidol_15_645 |
ESTHER : Navab_2004_Curr.Opin.Lipidol_15_645 |
PubMedSearch : Navab_2004_Curr.Opin.Lipidol_15_645 |
PubMedID: 15529023 |
Title : Apparent paradox of low-fat healthy diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a) - |
Author(s) : Navab M , Reddy ST , Van Lenten BJ , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 24 :392 , 2004 |
PubMedID: 15003971 |
Title : Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis - Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Hough G , Wagner A , Nakamura K , Garber DW , Datta G , Segrest JP , Hama S , Fogelman AM |
Ref : Curr Opin Investig Drugs , 4 :1100 , 2003 |
Abstract : Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
ESTHER : Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
PubMedSearch : Navab_2003_Curr.Opin.Investig.Drugs_4_1100 |
PubMedID: 14582455 |